NASDAQ : PAVM
PAVmed Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 1.97 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 13.78M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 13.36M |
| Enterprise Value | 26.35M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 6.99M |
| Shares Outstanding | 6.99M |
| Shares Change (YoY) | -18.99% |
| Shares Change (QoQ) | +296.60% |
| Owned by Insiders (%) | 23.02% |
| Owned by Institutions (%) | 7.72% |
| Float | 4.09M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 121.75 |
| Forward PS | 43.99 |
| PB Ratio | 0.39 |
| P/TBV Ratio | 0.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 237.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.19 |
| Quick Ratio | 1.00 |
| Debt / Equity | 0.88 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,405.42 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -64.78% |
| Return on Assets (ROA) | -39.69% |
| Return on Invested Capital (ROIC) | -43.29% |
| Return on Capital Employed (ROCE) | -73.92% |
| Weighted Average Cost of Capital (WACC) | 3.64% |
| Revenue Per Employee | $2,732 |
| Profits Per Employee | -$503,098 |
| Employee Count | 41 |
| Asset Turnover | 0.00 |
| Inventory Turnover | 1.52 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.70 |
| 52-Week Price Change | -85.16% |
| 50-Day Moving Average | 3.51 |
| 200-Day Moving Average | 6.54 |
| Relative Strength Index (RSI) | 25.94 |
| Average Volume (20 Days) | 11,416 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 12,717 |
| Short Previous Month | 12,621 |
| Short % of Shares Out | 0.18% |
| Short % of Float | 0.31% |
| Short Ratio (days to cover) | 0.56 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 112,000 |
| Gross Profit | -247,000 |
| Operating Income | -26.70M |
| Pretax Income | -16.43M |
| Net Income | -20.63M |
| EBITDA | -26.62M |
| EBIT | -26.70M |
| Loss Per Share | -$9.85 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 4.07M |
| Total Debt | 17.07M |
| Net Cash | -13.00M |
| Net Cash Per Share | -$1.86 |
| Equity (Book Value) | 19.31M |
| Book Value Per Share | 4.98 |
| Working Capital | 770,000 |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -7.73M |
| Capital Expenditures | -52,000 |
| Depreciation & Amortization | 79,000 |
| Net Borrowing | 3.85M |
| Free Cash Flow | -7.78M |
| FCF Per Share | -$1.11 |
Margins
| Measure | Value |
|---|
| Gross Margin | -220.54% |
| Operating Margin | -23,841.96% |
| Pretax Margin | -14,670.54% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 18.99% |
| Shareholder Yield | 18.99% |
| Earnings Yield | -515.83% |
| FCF Yield | -57.07% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $36.50 |
| Price Target Difference | 1,811.00% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 1,285.17% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jan 2, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -10.8 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |